Dr. Ying Wang obtained her bachelor degree from Jilin University, and Ph.D. from The University of Hong Kong. Dr. Wang joined the University of Macau as in 2013. Dr. Wang's research focuses on elucidating the structure-activity relationships of natural products and their derivatives, aiming to develop potent protein synthesis inhibitors and immune suppressive agents. Her research group has already identified the structural basis for andrographolide analogs as potent immunosuppressive agents, with the lead compound currently under preclinical investigation for the treatment of ulcerative colitis. Additionally, Dr. Wang’s team emphasizes studying signal transduction pathways activated by Toll-like receptors, inflammasomes, ubiquitination and deubiquitination, and nuclear receptors.

Professor Hong-Shuo Sun is currently a tenured Full Professor and PhD Supervisor in Departments of Surgery, and Physiology and Pharmacology, Faculty of Medicine, University of Toronto, Canada. Professor Sun is also a co-chair of Division of Anatomy in Faculty of Medicine, and a course director in Leslie Dan Faculty of Pharmacy, University of Toronto. He is also a member for Collaborative Program in Neuroscience, Heart and Stroke Richard Lewar Centre of Excellence, Cardiovascular Sciences Collaborative Program, and Banting & Best Diabetes Centre, in Faculty of Medicine, University of Toronto. He also is a member of the Canadian Society of Pharmacology and Therapeutics. Professor Sun is currently Editorial Board member of Acta Pharmacologica Sinica and Advanced Neurology. Hong graduated in Zhongshan Medical College, Sun Yat-Sen University, and completed his training as a cardiologist at the First University Hospital of Zhongshan Medical College, Guangzhou, China. He obtained his MSc degree in Cardiovascular Pharmacology, Faculty of Pharmacy, University of Alberta, Canada; and his PhD degree in Neurosciences in University of Calgary, Canada. His postdoctoral training was in University Health Network, Toronto, Canada. He has received many grants from NSERC, HSFC, CIHR, CFI, and NIH IGNIGHT, etc. and published more than 100 papers. His research focus is on studying the role of ion channels in neuroprotection and marine compounds in drug development for stroke and hypoxia.

Dr. Nurul Alimah Abdul Nasir is an Associate Professor at Universiti Teknologi MARA (UiTM) with over 10 years of experience in medical education and pharmacology, particularly in ocular pharmacology. She holds an MBBS from the University of Malaya (2008), a PhD in Pharmacology from UiTM (2017), and an MSc in Medical Education from the University of Malaya (2022). Her research focuses on investigating alternative treatments/adjuncts and their underlying mechanisms for ocular diseases such as diabetic retinopathy, cataracts and glaucoma. Other than that, she has a strong passion for curriculum development, assessment methods, instructional design, and technology-enhanced learning. Throughout her career, Dr. Nurul Alimah has held multiple academic roles, and currently serving as the Head for Department of Medical Education in Faculty of Medicine UiTM. She has published over 30 high-impact journal articles on ocular pharmacology and medical education, and secured several national and industrial research grants. Her contributions to innovation in ocular pharmacology research have been recognized with several Gold and Silver awards in innovation competitions. Additionally, she also contributes as the Associate Editor, Education in Medicine Journal (EIMJ). She is an active member of various professional bodies, including the Malaysian Society of Pharmacology and Physiology (serving as Honorary Treasurer), and the Malaysian Association of Education in Medical & Health Sciences (serving as Assistant Secretary). She is also a registered and active member of International Association for Health Professions Education (AMEE) and Asia-Pacific Association for Problem-Based Learning in Health Sciences (APA-PHS). Google Scholar: Scholar Profile | ORCID: 0000-0002-4285-7059 | Scopus Author ID: 55984413800

Dr. Chihiro Tohda was earned Ph.D. (Pharmaceutical Science) from Hokkaido University in 1994. She worked as a Research Fellowship for Young Scientists of JSPS and became an Assistant Professor in Research Institute for Wakan-yaku, Toyama Medical and Pharmaceutical University. She moved to Research Center for Ethnomedicines, Institute of Natural Medicine, Toyama Medical and Pharmaceutical University in 1996. From Nov. 1997, she worked at National Institute of Health (USA) for 4 months. She became an Associate Professor and Head of Division at of Neuromedical Science, Institute of Natural Medicine, University of Toyama in 2010, and a Full Professor and Head of Section of Neuromedical Science in 2017. Current Position is a Full Professor/Director of Institute of Natural Medicine, University of Toyama. She is engaged in research primarily focused on natural medicines, aiming to develop novel therapeutic approaches for refractory neurodegenerative diseases such as dementia, spinal cord injury, degenerative cervical myelopathy and glaucoma. She is also advancing clinical studies based on the outcomes of foundational research, with a keen awareness towards eventual societal implementation of our findings.

Yun-Shiuan Chen is currently a doctoral student in the Ph.D. Program in Clinical Drug Development of Herbal Medicine at Taipei Medical University, Taiwan. Her research focuses on natural products and their applications in osteoporosis, with a particular emphasis on Taiwanese folk medicinal plants. She integrates chemical analysis with in vitro cell and zebrafish models to evaluate bioactive compounds and their therapeutic potential in bone-related diseases. A recipient of the 2024 National Science and Technology Council (NSTC) Graduate Research Fellowship, her research outcomes have been published in the Journal of Natural Products and Pharmaceutical Biology.